In Vitro Inhibition of Angiogenesis by Heat and Low Ph Stable Hydroalcoholic Extract of Peganum Harmala Seeds Via Inhibition of Cell Proliferation and Suppression of Vegf Secretion Publisher Pubmed



Yavari N¹ ; Emamian F¹ ; Yarani R^{1, 2} ; Reza Mohammadimotlagh H¹ ; Mansouri K^{1, 3} ; Mostafaie A¹ Show Affiliations
Source: Pharmaceutical Biology Published:2015

Abstract

Context: Progression of cancer cells is completely dependent on its angiogenesis. Inhibition of tumor angiogenesis has shed new light on cancer treatment. As a result, anti-angiogenesis therapy represents one of the most significant advances in clinical oncology. Peganum harmala L. (Zygophyllaceae) is a native plant from the eastern Iranian region, which is used as a traditional folk medicine. Although some biological properties of this plant are determined, its effect on angiogenesis is still unclear. Objective: We investigated the anti-angiogenic effects of heat and low pH stable hydroalcoholic extract of P. harmala seeds on endothelial cells (ECs) proliferation and VEGF secretion. Materials and methods: Dried Peganum seeds were purchased from Kermanshah Traditional Bazar in 2011. Hydroalcoholic extract of dried seeds (0, 10, 20, 40, 60, 80, 100, 120, and 150μg/ml) was used for in vitro evaluation of its cytotoxicity, anti-proliferative, and anti-angiogenic effects on ECs. In vitro effect of the extract on VEGF secretion was assayed using ELISA. Results: Treatment with hydroalcoholic extract at seven different concentrations resulted in significant decrease of ECs proliferation and angiogenesis with an ID50 of ∼85μg/ml. VEGF secretion was (inhibited) decreased by the extracts at concentrations higher than 10μg/ml. Discussion and conclusion: Herbal plant extracts still attract attention owing to their fewer side effects comparing to synthetic drug agents. Current study indicated that hydroalcoholic extract of P. harmala seeds contains a potent anti-angiogenic component, which exerts its inhibitory effect mainly through down-regulation of essential mediators such as VEGF. © 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted.